The New England Journal of Medicine,
Desmoid tumors are difficult to treat when not amenable to resection. Two cases are reported in which there was regression of…
Asociación Colombiana de Medicina Interna,
Correspondence: Desmoid Tumors and Celecoxib with Sorafenib http://nej.md/2t1rDNn pic.twitter.com/tAys6LqTTQ